10500820

Source:http://linkedlifedata.com/resource/pubmed/id/10500820

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033325, umls-concept:C0220615, umls-concept:C0681842
pubmed:dateCreated	1999-11-4
pubmed:abstractText	We prospectively investigated the correlation between DISC-assay results and clinical response and also survival in patients with AML using a new method of evaluation.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0121103
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aminoglutethimide, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Danazol, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Idarubicin, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine
pubmed:status	MEDLINE
pubmed:issn	0065-2598
pubmed:author	pubmed-author:DiehlVV, pubmed-author:DimskiTT, pubmed-author:LathamAA, pubmed-author:PantkeBB, pubmed-author:SchinkötheTT, pubmed-author:StahlMM, pubmed-author:VoliotisDD, pubmed-author:WiedenmannSS
pubmed:issnType	Print
pubmed:volume	457
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	437-44
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10500820-Adult, pubmed-meshheading:10500820-Aminoglutethimide, pubmed-meshheading:10500820-Antineoplastic Agents, pubmed-meshheading:10500820-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10500820-Blast Crisis, pubmed-meshheading:10500820-Cell Survival, pubmed-meshheading:10500820-Cytarabine, pubmed-meshheading:10500820-Danazol, pubmed-meshheading:10500820-Drug Screening Assays, Antitumor, pubmed-meshheading:10500820-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:10500820-Humans, pubmed-meshheading:10500820-Idarubicin, pubmed-meshheading:10500820-Leukemia, Myeloid, Acute, pubmed-meshheading:10500820-Predictive Value of Tests, pubmed-meshheading:10500820-Prognosis, pubmed-meshheading:10500820-Prospective Studies, pubmed-meshheading:10500820-Regression Analysis, pubmed-meshheading:10500820-Remission Induction, pubmed-meshheading:10500820-Survival Analysis, pubmed-meshheading:10500820-Tamoxifen, pubmed-meshheading:10500820-Vidarabine
pubmed:year	1999
pubmed:articleTitle	Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
pubmed:affiliation	Clinic I for Internal Medicine, University of Cologne, Germany.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study